- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-33-0108443

Wellfino Pharmaceutical Private Limited
About Wellfino Pharmaceutical Private Limited
Data last updated:
Wellfino Pharmaceutical Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2021PTC364545. Its GSTIN is 27AADCW0130H1ZO (Maharashtra).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Krishna Kumar Ramlochan Dubey and Sanjay Krishna Pandey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalyan, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.5 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹5.51 Lakh (net margin 3.7%) and EBITDA of ₹8.66 Lakh (EBITDA margin 5.8%).
Wellfino Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0108443). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Wellfino Pharmaceutical
Contact details
Wellfino Pharmaceutical Private Limited's registered office is in Kalyan, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressShop No 3 And 4 Jadhav Gadh Building No 1, Godrej Hill Road Near Shani Mandir Khadakpada, Kalyan, Maharashtra, India – 421301
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wellfino Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wellfino Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Wellfino Pharmaceutical Private Limited, buy the company report.
Financials of Wellfino Pharmaceutical Private Limited
FY 2025 filings availableWellfino Pharmaceutical Private Limited reported revenue of ₹1.5 Cr (down 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 16% in the latest year. EBITDA fell 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹8.66 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5.51 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.8% | |||
| Net Profit Margin | 3.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Wellfino Pharmaceutical Private Limited, buy the company report.
Board of directors of Wellfino Pharmaceutical Private Limited
Wellfino Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Kumar Ramlochan Dubey | Director | 23 Jul 2021 | 5 Years 3 Months | Current |
| Sanjay Krishna Pandey Also directs: Rightkraft Ventures Private Limited | Director | 23 Jul 2021 | 5 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Wellfino Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wellfino Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wellfino Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCW0130H1ZO | Maharashtra | Active | 21 Aug 2021 |
To see the full GST registrations and return filing status of Wellfino Pharmaceutical Private Limited, buy the company report.
Recent activity
Wellfino Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Krishna Kumar Ramlochan Dubey was appointed as Director on 23 Jul 2021.
Frequently asked questions
Wellfino Pharmaceutical is an active private limited company based in Kalyan, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 July 2021 (5+ years old) and is registered under CIN U24299MH2021PTC364545.
Wellfino Pharmaceutical has 2 current directors:
- Krishna Kumar Ramlochan Dubey - Director
- Sanjay Krishna Pandey - Director
The latest financial statements of Wellfino Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Wellfino Pharmaceutical is 27AADCW0130H1ZO, registered in Maharashtra.
The CIN (Corporate Identification Number) of Wellfino Pharmaceutical is U24299MH2021PTC364545. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wellfino Pharmaceutical was incorporated on 23 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Krishna Kumar Ramlochan Dubey was appointed as Director on 23 Jul 2021. Sanjay Krishna Pandey was appointed as Director on 23 Jul 2021.
Yes, Wellfino Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0108443).
The registered office of Wellfino Pharmaceutical is at Shop No 3 And 4 Jadhav Gadh Building No 1, Godrej Hill Road Near Shani Mandir Khadakpada, Kalyan, Maharashtra, India – 421301.
Wellfino Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.

